Concepedia

Duloxetine 60 mg/day for the prevention of depressive recurrences:<i>post hoc</i>analyses from a recurrence prevention study

Katarina Kelin, Michael Berk, Marcus Spann, Doron Sagman, Joel Raskin, Daniel Walker, David Pérahia

International Journal of Clinical Practice · 2010 · 11 citations · 21 references

DOI

Abstract

Treatment with duloxetine 60 mg/day was associated with a longer time to depressive recurrence and a significantly lower recurrence rate compared with placebo.

References

21

A RATING SCALE FOR DEPRESSION

M. Hamilton · Journal of Neurology Neurosurgery & Psychiatry · 1960 · 32.2K citations · Full text

, , +7

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10

David V. Sheehan · The Journal of Clinical Psychiatry · 1998 · 19.4K citations

, , +8

Recurrence After Recovery From Major Depressive Disorder During 15 Years of Observational Follow-Up

Timothy I. Mueller, Andrew C. Leon, Martín Keller et al. · American Journal of Psychiatry · 1999 · 886 citations

The Visual Analog Scale in the Immediate Postoperative Period

Lauren J. DeLoach, Michael S. Higgins, Amy B. Caplan et al. · Anesthesia & Analgesia · 1998 · 709 citations

Fluoxetine Versus Sertraline and Paroxetine in Major Depressive Disorder

Maurizio Fava, Rajinder Judge, S. Hoog et al. · The Journal of Clinical Psychiatry · 2000 · 258 citations